NCT01759290View on ClinicalTrials.gov

ABSORB FIRST is a Registry Designed to Evaluate the Safety and Performance of Absorb Bioresorbable Vascular Scaffold (Absorb BVS) Used in Real-world Patients.

CompletedOBSERVATIONAL
Enrollment

1,800

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

August 31, 2015

Study Completion Date

December 31, 2015

Conditions
Chronic Total Occlusion of Coronary ArteryCoronary OcclusionCoronary Artery DiseaseCoronary Artery RestenosisCoronary Artery StenosisCoronary DiseaseCoronary Restenosis
Interventions
DEVICE

Absorb Bioresorbable Vascular Scaffold

Subjects receiving the Absorb Bioresorbable Vascular Scaffold

Trial Locations (1)

0886.537.933

Abbott Vascular International BVBA, Brussels

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY

NCT01759290 - ABSORB FIRST is a Registry Designed to Evaluate the Safety and Performance of Absorb Bioresorbable Vascular Scaffold (Absorb BVS) Used in Real-world Patients. | Biotech Hunter | Biotech Hunter